Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rithwik Ramachandran

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|May 18, 2011
Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2)Rithwik Ramachandran, Koichiro Mihara, Hyunjae Chung, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 14, 2013
Implantation serine proteinase 2 is a monomeric enzyme with mixed serine proteolytic activity and can silence signalling via proteinase activated receptorsNavneet Sharma, Jochen Fahr, Bernard Renaux, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 26, 2010
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survivalFarshid Noorbakhsh, Rithwik Ramachandran, Nicola Barsby, et al.
Chemmedchem|April 22, 2024
Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonists as Potential Migrastatics for Triple Negative Breast CancerWenjie Liu, Amr A K Mousa, Austin M Hopkins, et al.
The FEBS Journal|August 10, 2025
Defining the interactome of the pancreas-specific SPCA2 isoform (SPCA2C) identifies unique links to store-operated Ca<sup>2+</sup> entryPetra Samardzija, Melissa A Fenech, Oneeb Hassan, et al.
Bioorganic Chemistry|March 30, 2026
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancerWenjie Liu, Amr A K Mousa, Guillem Dayer, et al.
European Journal of Medicinal Chemistry|December 17, 2022
Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imagingJordan C LeSarge, Pierre Thibeault, Lihai Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2010
The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activationSimeon E Goldblum, Usha Rai, Amit Tripathi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2013
TRPM8 activation attenuates inflammatory responses in mouse models of colitisRithwik Ramachandran, Eric Hyun, Liena Zhao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systemsMahmoud Saifeddine, Michelle L Seymour, Yu-Pei Xiao, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|May 18, 2011
Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2)Rithwik Ramachandran, Koichiro Mihara, Hyunjae Chung, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 14, 2013
Implantation serine proteinase 2 is a monomeric enzyme with mixed serine proteolytic activity and can silence signalling via proteinase activated receptorsNavneet Sharma, Jochen Fahr, Bernard Renaux, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 26, 2010
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survivalFarshid Noorbakhsh, Rithwik Ramachandran, Nicola Barsby, et al.
Chemmedchem|April 22, 2024
Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonists as Potential Migrastatics for Triple Negative Breast CancerWenjie Liu, Amr A K Mousa, Austin M Hopkins, et al.
The FEBS Journal|August 10, 2025
Defining the interactome of the pancreas-specific SPCA2 isoform (SPCA2C) identifies unique links to store-operated Ca<sup>2+</sup> entryPetra Samardzija, Melissa A Fenech, Oneeb Hassan, et al.
Bioorganic Chemistry|March 30, 2026
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancerWenjie Liu, Amr A K Mousa, Guillem Dayer, et al.
European Journal of Medicinal Chemistry|December 17, 2022
Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imagingJordan C LeSarge, Pierre Thibeault, Lihai Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2010
The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activationSimeon E Goldblum, Usha Rai, Amit Tripathi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2013
TRPM8 activation attenuates inflammatory responses in mouse models of colitisRithwik Ramachandran, Eric Hyun, Liena Zhao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systemsMahmoud Saifeddine, Michelle L Seymour, Yu-Pei Xiao, et al.
Pageof 6